George M. Eliopoulos mainly investigates Microbiology, Antibiotics, Staphylococcus aureus, Antibacterial agent and Vancomycin. His research in Microbiology intersects with topics in Daptomycin, Virulence and Linezolid. The Antibiotics study combines topics in areas such as Pseudomonas aeruginosa, Bacteria and Antimicrobial.
His research integrates issues of Glycopeptide and Bacteremia in his study of Staphylococcus aureus. His biological study spans a wide range of topics, including Logistic regression, Immunology, Imipenem, Intensive care unit and Cohort. His Vancomycin research integrates issues from Enterococcus faecalis, Internal medicine and Gentamicin.
His scientific interests lie mostly in Microbiology, Antibiotics, Antibacterial agent, Antimicrobial and Vancomycin. His Microbiology research incorporates elements of Enterococcus faecalis and Staphylococcus aureus. George M. Eliopoulos has researched Antibiotics in several fields, including Internal medicine and Endocarditis.
George M. Eliopoulos usually deals with Antibacterial agent and limits it to topics linked to Minimum inhibitory concentration and Penicillin. His Antimicrobial study also includes fields such as
George M. Eliopoulos mostly deals with Microbiology, Staphylococcus aureus, Antibiotics, Vancomycin and Daptomycin. George M. Eliopoulos is studying Fosfomycin, which is a component of Microbiology. His studies deal with areas such as Antibacterial agent, Gene and Point mutation as well as Staphylococcus aureus.
His work on Micrococcaceae as part of general Antibacterial agent research is frequently linked to RRNA Operon and 23S ribosomal RNA, bridging the gap between disciplines. His Antibiotics study integrates concerns from other disciplines, such as Antibacterial activity, Eperezolid, Potency and Piperazine. His work in Vancomycin addresses subjects such as Enterococcus faecium, which are connected to disciplines such as Antibiotic resistance, Amp resistance, Drug resistance, Teicoplanin and Telavancin.
George M. Eliopoulos spends much of his time researching Microbiology, Vancomycin, Staphylococcus aureus, Antibiotics and Virulence. His studies in Microbiology integrate themes in fields like Carbapenem-resistant enterobacteriaceae and Daptomycin. His work investigates the relationship between Daptomycin and topics such as Antibacterial agent that intersect with problems in Methicillin-resistant Staphylococcus aureus, Methicillin Susceptible Staphylococcus Aureus and Lipopeptide.
His Vancomycin research is multidisciplinary, relying on both Tigecycline and Enterococcus faecium. His studies examine the connections between Staphylococcus aureus and genetics, as well as such issues in Mutation, with regards to Hemolysin and Whole genome sequencing. He works mostly in the field of Virulence, limiting it down to topics relating to Acinetobacter baumannii and, in certain cases, Acinetobacter lwoffii, Neisseriaceae, Quorum sensing and Eukaryote.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Linezolid resistance in a clinical isolate of Staphylococcus aureus
Sotirios Tsiodras;Sotirios Tsiodras;Howard S Gold;Howard S Gold;George Sakoulas;George Sakoulas;George M Eliopoulos;George M Eliopoulos.
The Lancet (2001)
Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
George Sakoulas;Pamela A. Moise-Broder;Jerome Schentag;Alan Forrest.
Journal of Clinical Microbiology (2004)
The Sanford guide to antimicrobial therapy
David N. Gilbert;Robert C. Moellering;George M. Eliopoulos;Henry F. Chambers.
Emergence of Antibiotic-Resistant Pseudomonas aeruginosa: Comparison of Risks Associated with Different Antipseudomonal Agents
Yehuda Carmeli;Nicolas Troillet;George M. Eliopoulos;Matthew H. Samore.
Antimicrobial Agents and Chemotherapy (1999)
New β-Lactamases in Gram-Negative Bacteria: Diversity and Impact on the Selection of Antimicrobial Therapy
George M. Eliopoulos;Karen Bush.
Clinical Infectious Diseases (2001)
Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility.
L B Rice;S H Willey;G A Papanicolaou;A A Medeiros.
Antimicrobial Agents and Chemotherapy (1990)
Accessory Gene Regulator (agr) Locus in Geographically Diverse Staphylococcus aureus Isolates with Reduced Susceptibility to Vancomycin
George Sakoulas;George M. Eliopoulos;Robert C. Moellering;Christine Wennersten.
Antimicrobial Agents and Chemotherapy (2002)
Accessory Gene Regulator Group II Polymorphism in Methicillin-Resistant Staphylococcus aureus Is Predictive of Failure of Vancomycin Therapy
Pamela A. Moise-Broder;George Sakoulas;George M. Eliopoulos;Jerome J. Schentag.
Clinical Infectious Diseases (2004)
Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein.
Vance G. Fowler;George Sakoulas;Lauren M. McIntyre;Lauren M. McIntyre;Venkata G. Meka.
The Journal of Infectious Diseases (2004)
Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2.
Richard E. Person;Feng Qian Li;Zhijun Duan;Kathleen F. Benson.
Nature Genetics (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: